Sotera Health Company

SHC Healthcare Diagnostics & Research

Sotera Health Company’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 5.74% from fiscal 2024. In the quarter to June 2026, revenue grew 9.18%, EPS grew 533.3%, free cash flow grew 60.6% and total debt fell 3.54%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

17.89 0.18 −1.00%
Market cap
$5.2B
P/E
31.4×
Fwd P/E
23.7×
Dividend yield
—
F-score
7/9
Altman Z
1.76
Beneish M
−2.75
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

82.79 65.33 34.98 31.14
P/S ratio
3.88 4.30 3.44 4.17
P/FCF ratio
51.59 33.58 42.18 45.01
P/Operating CF
62.80 48.58 138.79 57.32
P/B ratio
8.12 8.27 6.56 7.62
EV/Sales
5.57 5.93 5.05 5.71
EV/EBITDA
12.98 13.68 11.69 13.10
EV/FCF
73.94 46.23 61.96 61.64
Current Ratio
2.38 2.46 2.82 2.80
Net Debt/EBITDA
13.75 13.55 17.72 13.22
Debt/Equity
4.06 3.69 3.58 3.35
Earnings Yield
1.21% 1.53% 2.86% 3.21%
Free Cash Flow Yield
1.94% 2.98% 2.37% 2.22%
Free Cash Flow per Share
0.12 0.18 (0.06) 0.15
Book value per Share
1.94 2.13 2.19 2.33
Free Cash Flow
34.98 52.41 (16.73) 42.05
EV/EBIT
18.63 19.05 15.76 17.40
Other line items

Show all line items

Columns are period end dates